P

Inventor

HUANG LU

US59 patents
⚠️ This page may combine multiple inventors who share the name “HUANG LU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HUAWEI TECH CO LTD

23 patents
USD853980SJul 16, 2019

Terminal device

HUAWEI TECH CO LTD53 citations98
USD864141SOct 22, 2019

Mobile phone

HUAWEI TECH CO LTD44 citations97
USD1063878SFeb 25, 2025

Mobile phone

HUAWEI TECH CO LTD7 citations86
USD1062673SFeb 18, 2025

Mobile phone

HUAWEI TECH CO LTD6 citations86
USD1062670SFeb 18, 2025

Mobile phone

HUAWEI TECH CO LTD6 citations86
USD1062669SFeb 18, 2025

Mobile phone

HUAWEI TECH CO LTD7 citations86
USD925511SJul 20, 2021

Mobile phone

HUAWEI TECH CO LTD10 citations85
USD1083860SJul 15, 2025

Mobile phone

HUAWEI TECH CO LTD2 citations75
USD1083859SJul 15, 2025

Mobile phone

HUAWEI TECH CO LTD3 citations75
USD1074632SMay 13, 2025

Mobile phone

HUAWEI TECH CO LTD3 citations75
USD1062672SFeb 18, 2025

Mobile phone

HUAWEI TECH CO LTD4 citations75
USD1062668SFeb 18, 2025

Mobile phone

HUAWEI TECH CO LTD4 citations75
USD1062671SFeb 18, 2025

Mobile phone

HUAWEI TECH CO LTD4 citations75
USD1062678SFeb 18, 2025

Mobile phone

HUAWEI TECH CO LTD5 citations75
USD1062676SFeb 18, 2025

Mobile phone

HUAWEI TECH CO LTD5 citations75
USD1062675SFeb 18, 2025

Mobile phone

HUAWEI TECH CO LTD4 citations75
USD1062674SFeb 18, 2025

Mobile phone

HUAWEI TECH CO LTD4 citations75
USD1062705SFeb 18, 2025

Mobile phone

HUAWEI TECH CO LTD5 citations75
USD1055011SDec 24, 2024

Mobile phone

HUAWEI TECH CO LTD4 citations75
USD955371SJun 21, 2022

Mobile phone

HUAWEI TECH CO LTD1 citations73
USD960120SAug 9, 2022

Mobile phone

HUAWEI TECH CO LTD3 citations72
USD1103133SNov 25, 2025

Mobile phone

HUAWEI TECH CO LTD0 citations62
USD1083858SJul 15, 2025

Mobile phone

HUAWEI TECH CO LTD0 citations62

NOVARTIS AG

13 patents
US10525083B2Jan 7, 2020

Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain

NOVARTIS AG15 citations93
US10253086B2Apr 9, 2019

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell

NOVARTIS AG37 citations93
US11149076B2Oct 19, 2021

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell

NOVARTIS AG9 citations84
US11492409B2Nov 8, 2022

Binding molecules against BCMA and uses thereof

NOVARTIS AG10 citations83
US11026976B2Jun 8, 2021

Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain

NOVARTIS AG6 citations82
US12344657B2Jul 1, 2025

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell

NOVARTIS AG1 citations73
US12275795B2Apr 15, 2025

Binding molecules against BCMA and uses thereof

NOVARTIS AG2 citations72
US11608382B2Mar 21, 2023

BCMA chimeric antigen receptors and uses thereof

NOVARTIS AG4 citations72
US11872249B2Jan 16, 2024

Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain

NOVARTIS AG2 citations71
USRE49847EFeb 27, 2024

Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain

NOVARTIS AG0 citations61
US11952428B2Apr 9, 2024

BCMA chimeric antigen receptors and uses thereof

NOVARTIS AG0 citations59
US11939389B2Mar 26, 2024

BCMA chimeric antigen receptors and uses thereof

NOVARTIS AG0 citations59
US12383601B2Aug 12, 2025

Chimeric antigen receptors and uses thereof

NOVARTIS AG1 citations57

GM GLOBAL TECH OPERATIONS LLC

3 patents

HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC

3 patents

UBER TECHNOLOGIES INC

2 patents

SHENZHEN LUBON TECH CO LTD

1 patent

HUBEI BIO-PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC

1 patent

BEIJING BYTEDANCE NETWORK TECH CO LTD

1 patent

UNIV SOUTHWEST JIAOTONG

1 patent

CHINA MOBILE COMM CORP

1 patent

IBM

1 patent

Showing the top 50 of 59 patents by PatentIndex Score.